HealthQuill Pharma
Pfizer Inc., announced its experimental drug for treating a lower respiratory tract disease for adults between 18- to 59 years has met its primary goals in trials.
Drugs Health Pharma

Last-stage trials achieve “positive” results for RSV drug: Pfizer says

HQ Team April 9, 2024: Pfizer Inc., announced its experimental drug for treating a lower respiratory tract disease for adults between 18- to.

Read More
Climate Health Pharma

PFAS found in leading brands of bandages, says report

HQ Team April 8, 2024: A study commissioned by the Environmental Health News and consumer watchdog site Mamavation, found that many bandage brands.

Read More
Amylyx Pharmaceuticals announced it has started a process with the USFDA and Health Canada to voluntarily discontinue the marketing authorisations for its amyotrophic lateral sclerosis (ALS) therapy after the drug failed in a last-stage trial.
Drugs Health Pharma

Amylyx Pharma pulls out ALS therapy drug from US, Canada

HQ Team April 4, 2024: Amylyx Pharmaceuticals announced it has started a process with the USFDA and Health Canada to voluntarily discontinue the.

Read More
Britain’s Competition and Markets Authority (CMA) expressed concerns over Theramex's planned acquisition of Femoston and Duphaston stating it may reduce competition and choice for hormone replacement therapy (HRT) treatments in the country.
Drugs Health Pharma

Britain’s CMA raises concern over Theramex’s Femoston buy

HQ Team April 4, 2024: Britain’s Competition and Markets Authority (CMA) expressed concerns over Theramex’s planned acquisition of Femoston and Duphaston stating it.

Read More
The USFDA approved Swiss-based Basilea Pharmaceutica International’s Zevtera injection for the treatment of staphylococcus aureus bloodstream infections and skin infections in adults and community-acquired bacterial pneumonia in patients three months to 18 years, and adults. 
Drugs Health Pharma

Swiss-based Basilea Pharmaceutical’s antimicrobial drug gets FDA nod 

HQ Team April 4, 2024: The USFDA approved Swiss-based Basilea Pharmaceutica International’s Zevtera injection for the treatment of staphylococcus aureus bloodstream infections and.

Read More
Humans’ lack of immunity may rapidly result in the transmission of bird flu among people if the avian influenza virus acquires the ability to spread quickly, according to the European Food Safety Authority (EFSA). 
Drugs Health Pharma

EFSA issues warning on bird flu spread, says humans lack immunity  

HQ Team April 3, 2024: Humans’ lack of immunity may rapidly result in the transmission of bird flu among people if the avian.

Read More
The death of about 100,000 cattle in India, two years ago, has been tracked to a viral infection, or lumpy skin disease outbreak, by scientists at the Indian Institute of Science, who said it was the second major outbreak in the South Asian nation.
Drugs Health Pharma

Indian scientists track 2022 viral infection in cattle to lumpy skin disease

HQ Team April 3, 2024: The deaths of about 100,000 cattle in India, which started two years ago, have been tracked to a.

Read More
A smartphone can measure the glucose levels of diabetic patients, diagnose disease and detect environmental toxins, with the help of built-in magnetic compasses.
Drugs Medical Pharma

Smartphone’s compass can detect glucose levels, toxins, diseases

HQ Team April 3, 2024: A smartphone can measure the glucose levels of diabetic patients, diagnose disease and detect environmental toxins, with the.

Read More
Policymaking and planning should be inclusive, safe and flexible. The “sanity” of a city is the well-being of its residents, and it is time we focus on achieving it.
Climate Health Opinion Pharma

Opinion: ‘Sanity’ is sacrosanct, city residents’ mental health sacred

By Aparna S April 3, 2024: Over the last decade and until 2022 about one-third of India’s 1.4 billion people have become city.

Read More
Israel’s Teva Pharmaceutical Industries, and US-based Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.
Drugs Health Pharma

Israel’s Teva in pact with Launch Therapeutics for asthma drug

Israel’s Teva Pharmaceutical Industries, and US-based Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.

Read More